from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0857/-

LFCtreatmentdescriptionclass of inhibitor

-0.206

Amikacinug/mL Amikacintranslation

-0.328

Cap5-10ug/mL Capreomycintranslation

-0.286

Rox10-50 ug/mL Roxithromycintranslation

-0.367

SM2-5 ug/mL Streptomycintranslation

-1.312

Tet5-10 ug/mL Tetracyclinetranslation

-0.470

Rif0.2-5ug/mL Rifampicintranscription

-0.600

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.019

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.848

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.630

CPZ10-50 ug/mL Chlorpromazinerespiration

0.392

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.074

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.282

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.724

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.630

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.208

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.528

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.301

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.083

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.074

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.097

KCN5-20 ug/mL Potassium cyaniderespiration

0.363

NaN30.2-2 mM Sodium aziderespiration

-0.627

Nigericin50 uM Nigericinrespiration

0.373

TRC10-150 ug/mL Triclosanrespiration

0.979

TRZ10-25 ug/mL Thioridazinerespiration

0.664

Valinomycin0.5-10 uM Valinomycinrespiration

1.602

ZnSO42 mM ZnSO4respiration

0.073

menadione6-10 ug/mL Menadionerespiration

0.041

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.412

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.779

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.149

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.033

NRP_1Non-replicating persistence stage 1dosRassociated

-0.298

Amp0.2mg/mL AmpicillincellWall

-0.257

Cephalexin20-100 ug/mL CephalexincellWall

-0.252

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.451

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.666

EMB10-20 ug/mL EthambutolcellWall

0.291

Eta12-40 ug/mL EthionamidecellWall

0.687

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.067

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.046

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.038

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.240

BZA0.12 mg/mL BenzamidearomaticAmides

0.095

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.037

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.434

H2O24 mM hydrogen peroxideDNAdamaging

-0.163

Levo10 ug/mL LevofloxacinDNAdamaging

-1.083

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.046

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.633

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.127

UVUV-irradiationDNAdamaging

0.352

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.811

Antimycin12.5-50 ug/mL Antimycin A?

-0.007

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.099

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.135

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.041

PA8240.2-2 ug/mL PA-824?

1.553

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.308

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.209

Verapamil50 uM Verapamil?

-0.472

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.742

methoxatin10-20 ug/mL Methoxatin?